**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 5787-71-3 |Girard's Reagent D | 98% | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN F
Risk Phrases: 11 20/22 36/37/38 44
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Highly flammable. Harmful by inhalation and if swallowed. Irritating
to eyes, respiratory system and skin. Risk of explosion if heated
under confinement.The toxicological properties of this material have
not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. The toxicological properties of this
substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Harmful if inhaled.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Flammable
solid. Violently decomposes when heated under confinement. May burn
rapidly with flare burning effect. May re-ignite after fire is
extinguished. Containers may explode if exposed to fire. Dangerous
fire hazard in the form of dust when exposed to heat or flame.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
Contact professional fire-fighters immediately. Cool containers with
flooding quantities of water until well after fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Scoop up with a nonsparking tool, then
place into a suitable container for disposal. Avoid generating dusty
conditions. Remove all sources of ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Minimize dust generation and accumulation. Avoid breathing dust,
vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Empty containers retain product residue, (liquid and/or vapor), and
can be dangerous. Keep container tightly closed. Keep away from heat,
sparks and flame. Avoid ingestion and inhalation. Use with adequate
ventilation. Do not pressurize, cut, weld, braze, solder, drill,
grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a cool, dry place. Store in a tightly closed
container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Exposure Limits
CAS# 5787-71-3:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 208-212 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C4H11N3O.2HCl
Molecular Weight: 190.07
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. Risk of explosion if heated under
confinement.
Conditions to Avoid:
Ignition sources, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong reducing agents, strong bases, strong
acids.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide, nitrogen oxides
(NOx) and ammonia (NH3), chlorine.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 5787-71-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Girard's Reagent D -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: FLAMMABLE SOLID, ORGANIC, N.O.S.
Hazard Class: 4.1
UN Number: 1325
Packing Group: III
IMO
Shipping Name: FLAMMABLE SOLID, ORGANIC, N.O.S.
Hazard Class: 4.1
UN Number: 1325
Packing Group: III
RID/ADR
Shipping Name: FLAMMABLE SOLID, ORGANIC, N.O.S.
Hazard Class: 4.1
UN Number: 1325
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN F
Risk Phrases:
R 11 Highly flammable.
R 20/22 Harmful by inhalation and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 44 Risk of explosion if heated under confinement.
Safety Phrases:
S 16 Keep away from sources of ignition - No
smoking.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 5787-71-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5787-71-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5787-71-3 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/05/1999 Revision #5 Date: 10/28/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
N,N-Diisopropylisobutyramide
| 6282-98-0 |
|
M-Carborane
| 16986-24-6 |
|
3-Methoxyphenethylamine
| 2039-67-0 |
|
3,4-(Methylenedioxy)phenylacetic Acid, 98.5+% (Titr.)
| 2861-28-1 |
|
6-Amino-2-methyl-2-heptanol, 98%
| 372-66-7 |
|
6-Amino-2-Methyl-2-Heptanol Hydrochloride, 98+% (Titr.)
| 543-15-7 |
|
1-(3-Methoxyphenyl)-piperazine, 98%
| 16015-71-7 |
|
Isopropyl-??-D-thiogalactopyranoside, DNase, RNase, Protease free
| 367-93-1 |
|
Duolite mb6113, non-regenerable mixed bed resin
| 7732-18-5 |
|
Linolenic acid, 99%
| 463-40-1 |
|
Beta-Tetralone, 95%
| 530-93-8 |
|
Girard's Reagent D
| 5787-71-3 |
|
DL-XYLOSE, 98%
| 41247-05-6 |
|
Esculetin, 98%
| 305-01-1 |
|
Scopoletin, 95%
| 92-61-5 |
|
Sarcosine ethyl ester hydrochloride, 97+%
| 52605-49-9 |
|
Rhapontin, 95%
| 155-58-8 |
|
Pentaerythrityl Tetraacetate
| 597-71-7 |
|
L-4-Chlorophenylalanine, 98%
| 14173-39-8 |
|
(+)-Bicuculline, 98%
| 485-49-4 |
|
Phosphoenolpyruvic Acid, Monopotassium Salt, 99%
| 4265-07-0 |
|
N-(2-Aminoethyl)-Piperidine, 98%
| 27578-60-5 |
|
Coumarin 338, Laser Grade, 99% (UV-Vis)
| 62669-75-4 |
|
beta-D-Glucose pentaacetate, 98%
| 604-69-3 |
|
Harmine, 98%
| 442-51-3 |
|
l-Prolinamide, 98%
| 7531-52-4 |
|
Methyl carbamate, 99%
| 598-55-0 |
|
L-Proline methyl ester hydrochloride, 98%
| 2133-40-6 |
|
Phenyl-beta-d-galactopyranoside, 98%
| 2818-58-8 |
|
Dl-cystine, 99%
| 923-32-0 |
|
6-(Carbobenzyloxyamino)caproic acid, 98%
| 1947-00-8 |
|
2,5-Anhydro-D-Mannitol, 99%
| 41107-82-8 |
|
Cytidine 5'-Monophosphate, Disodium Salt Hydrate
| 6757-06-8 |
|
Beta-Alanine Ethyl Ester Hydrochloride, 98 %
| 4244-84-2 |
|
Ethyl (R)-(-)-2-pyrrolidone-5-carboxylate, 99%
| 68766-96-1 |
|
9-Fluorenylmethyl pentafluorophenyl carbonate, 98%
| 88744-04-1 |
|
2,3:5,6-Di-O-isopropylidine-alpha-D-mannofuranose, 98%
| 14131-84-1 |
|
o-(1,2-Dihydro-2-oxo-1-pyridyl)-n,n,n',n'- tetramethyluronium
| 125700-71-2 |
|
(s)-(+)-5-(Hydroxymethyl)-2-pyrrolidinone, 97%
| 17342-08-4 |
|
L-Serinamide hydrochloride, 98%
| 65414-74-6 |
|
o-Benzotriazol-1-yl-n,n,n',n'-tetramethyluronium tetrafluoroborate,
| 125700-67-6 |
|
O-(n-succinimidyl)-n,n,n',n'-tetramethyl uronium tetrafluoroborate,
| 105832-38-0 |
|
Octafluoronaphthalene, 96%
| 313-72-4 |
|
n-(tert-Butoxycarbonyl)-l-laspartic acid, 99%
| 13726-67-5 |
|
n-alpha-Carbobenzyloxy-l-tryptophan, 99%
| 7432-21-5 |
|
l-Cysteine methyl ester hydrochloride, 98%
| 18598-63-5 |
|
N-Acetyl-5-Hydroxytryptamine, 99%
| 1210-83-9 |
|
DL-Tryptophan, 99+%
| 54-12-6 |
|
3-Bromobenzoic hydrazide, 98%
| 39115-96-3 |
|
2-Amino-5-bromobenzoic acid, 97%
| 5794-88-7 |
|
|